JointHealth™ express October 14, 2021
With more biosimilar biologic medications becoming available in Canada, arthritis patients and healthcare providers need to understand what biosimilars are and how they are approved and being used. In this episode of Arthritis at Home, Kelly Lendvoy interviews ACE President, Cheryl Koehn about the new look for one of Canada’s most comprehensive biosimilar information resources for people living with arthritis.
Check out these helpful resources to learn more:
With more biosimilar biologic medications becoming available in Canada, arthritis patients and healthcare providers need to understand what biosimilars are and how they are approved and being used. In this episode of Arthritis at Home, Kelly Lendvoy interviews ACE President, Cheryl Koehn about the new look for one of Canada’s most comprehensive biosimilar information resources for people living with arthritis.
Check out these helpful resources to learn more:
Arthritis Consumer Experts
ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealth™ information and education programs.